QIAGEN Reports Results for First Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Qiagen NV (QGEN) PT Raised to $31.50 at Evercore ISI
May 3, 2017 11:01 AM EDTEvercore ISI raised its price target on Qiagen NV (NASDAQ: QGEN) to $31.50 (from $30.00) while maintaining a Outperform rating following results, saying the turnaround remains on track.
Analyst Vijay Kumar noted constant currency revenue beat driven by slightly better M&A contribution and generally... More
Qiagen (QGEN) Misses Q1 EPS by 1c; Reaffirms
May 2, 2017 4:06 PM EDTQiagen (NASDAQ: QGEN) reported Q1 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $306.89 million.
QIAGEN reaffirms full-year 2017 outlook for 6-7% CER sales growth and adjusted EPS target before restructuring... More



